The pharmaceutical company Amgen is suing the Colorado Prescription Drug Affordability Board after the price of one of its ...

Pharmaceutical company Amgen sued the Colorado Prescription Drug Affordability Board over a price cap the board placed on Enbrel.

The new lawsuit argues that the board’s action conflicted with federal patent laws by not allowing the company to charge as much as it wants.

Colorado finalized the nation’s first prescription drug price cap Oct. 3, establishing an upper payment limit for Enbrel, an autoimmune medication, through the state’s prescription drug affordability ...

Question: I paid so much for my Eliquis this year, will I have to pay that much next year too? Answer: The good news is no, seniors will not pay as much for Eliquis as well as nine other common ...

Amgen reported stronger-than-expected quarterly financial results, raising its full-year forecast. The biotech company's 12% ...